Mamat @ Yusof, M.N.; Chew, K.T.; Hafizz, A.M.H.A.; Abd Azman, S.H.; Ab Razak, W.S.; Hamizan, M.R.; Kampan, N.C.; Shafiee, M.N.
Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis. Cancers 2023, 15, 4032.
https://doi.org/10.3390/cancers15164032
AMA Style
Mamat @ Yusof MN, Chew KT, Hafizz AMHA, Abd Azman SH, Ab Razak WS, Hamizan MR, Kampan NC, Shafiee MN.
Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis. Cancers. 2023; 15(16):4032.
https://doi.org/10.3390/cancers15164032
Chicago/Turabian Style
Mamat @ Yusof, Mohd Nazzary, Kah Teik Chew, Abdul Muzhill Hannaan Abdul Hafizz, Siti Hajar Abd Azman, Wira Sofran Ab Razak, Muhammad Rafi’uddin Hamizan, Nirmala Chandralega Kampan, and Mohamad Nasir Shafiee.
2023. "Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis" Cancers 15, no. 16: 4032.
https://doi.org/10.3390/cancers15164032
APA Style
Mamat @ Yusof, M. N., Chew, K. T., Hafizz, A. M. H. A., Abd Azman, S. H., Ab Razak, W. S., Hamizan, M. R., Kampan, N. C., & Shafiee, M. N.
(2023). Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis. Cancers, 15(16), 4032.
https://doi.org/10.3390/cancers15164032
